|
Search
This Site

Too
Much of a Good Thing?
A cholesterol drug is pulled after 31 people die. What happened? A microscopic
view of cholesterol.
August
10 This week, the German pharmaceutical company Bayer AG voluntarily
pulled its cholesterol-reducing medication Baycol from the market after
31 deaths had been attributed to its use. Some 700,000 Americans have
been taking the drug. The patients who died had severe rhabdomyolysis,
a condition in which in muscle tissue breaks down, eventually getting
into the bloodstream and damaging the kidneys. NEWSWEEKs Laura Fording
asked Dr. Jay Cohen, author of the upcoming book Over Dose: The
Case Against the Drug Companies (Tarcher/Putnam, Oct. 2001) for
his take on what happened.
|
 |
![]() |
|
|
 |
|
|
|
=
News Release =
|
|
![]() |
|
![]() |
FDA today announced that Bayer Pharmaceutical Division is voluntarily withdrawing
Baycol (cerivastatin) from the U.S. market because of reports of
sometimes fatal rhabdomyolysis. Read
More...
Bayer
said it recalled Baycol after it received reports that the drug
caused deterioration in muscle tissue, a condition called rhabdomyolysis,
which is known to cause severe pain and potential kidney failure.
Read
More...
A CNN
Europe article from August the 13th, 2001. LONDON (CNN)
-- Germany's Bayer said on Monday 52 people are thought to have
died after taking the anti-cholesterol product Baycol, its fastest-growing
drug.
Read
More...
|
|
 |
|
NBC Nightly
News Report
|
|


Click to here to view video for the latest information on the Baycol
Recall.
NBC
NEWS AND
WIRE REPORTS
|
|